Salarius Pharmaceuticals Inc. (SLRX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Salarius Pharmaceuticals ...

    NASDAQ: SLRX · Real-Time Price · USD
    4.97
    -0.79 (-13.72%)
    At close: Sep 02, 2025, 3:59 PM

    Salarius Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.32 -1.36 -0.83 -1.61
    PEG Ratio
    		 -0.00 0.01 0.01 0.04
    PS Ratio
    		 n/a n/a n/a 11.15
    PB Ratio
    		 1.18 3.23 2.52 0.53
    P/FCF Ratio
    		 -0.39 -1.33 -1.37 -2.01
    P/OCF Ratio
    		 -0.39 -1.33 -1.49 -2.01
    OCF/S Ratio
    		 n/a n/a n/a -5.54
    Debt / Equity Ratio
    		 0.15 0.05 n/a n/a
    Quick Ratio
    		 1.98 5.02 3.40 14.29
    Current Ratio
    		 1.98 5.02 3.40 14.29
    Asset Turnover
    		 n/a n/a n/a 0.05
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -3.69 -2.37 -3.02 -0.33
    Return on Assets
    		 -1.84 -1.9 -2.14 -0.31
    Return on Invested Capital
    		 -3.31 n/a -2.21 -0.33
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a 0.99
    Net Profit Margin
    		 n/a n/a n/a -6.94
    Pretax Profit Margin
    		 n/a n/a n/a -6.94
    Operating Profit Margin
    		 n/a n/a n/a -6.96
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a -6.95

    Add to Watchlist